Clinical trials
Phase 2 Schizophrenia Spectrum and Other Psychotic Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| MapLight Therapeutics | 2 |
| Region Örebro County | 2 |
| Anders Fink-Jensen, MD, DMSci | 1 |
| Brown University | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Institute on Drug Abuse (NIDA) | 1 |
| University Hospital, Strasbourg, France | 1 |
| University of Cologne | 1 |
| University of Manchester | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia Spectrum and Other Psychotic Disorders | 14 |
| Schizophrenia | 8 |
| Mental Disorders | 6 |
| Psychotic Disorders | 5 |
| Alzheimer Disease | 2 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Dementia | 2 |
| Hallucinations | 2 |
| Nervous System Diseases | 2 |
Trials
Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.